Last Updated: 12/03/2025
Evaluation of anti-CSP mAbs in huFcgR Tg mice
Objectives
To identify and optimize potent anti-CSP mAbs to protect vulnerable populations in low and middle income countries from malaria.
Principal Institution
Principal Investigators / Focal Persons
External reference
Date
Nov 2020 — Aug 2023
Total Project Funding
$402,991
Funding Details
Gates Foundation (GF), United States
INV-005226
Country / Project Site(s)


